Background: Deep learning has shown promising results regarding Alzheimer's disease (AD) studies. In the meantime, heatmap methods have emerged as a popular tool to visualize deep learning models, enhancing the transparency and explainability of deep learning. However, when no ground truth is available, the heatmap methods are particularly difficult to trust. In the neuroimaging field, meta-analysis is often conducted to reduce heterogeneity and reveal the true positive. Thus, in this work, we aim at validating heatmap methods by quantifying the overlap of a ground truth map provided by a large meta-analysis and heatmaps derived by three methods, the Layer-wise Relevance Propagation (LRP) method, the Integrated Gradients (IG) method, and the Guided grad-CAM (GGC) method from convolutional neural network achieving state-of-the-art classification performance for AD classification on a sample of MRI scans from ADNI.
Method: 502 ADNI participants were included in this study with 250 AD participants and 252 healthy controls. Those brain scans were trained by five different 3D CNN architectures. Three CNN heatmap methods were applied on trained models to produce a heatmap indicating which voxels were the most important when classifying AD and control participants. The structural MRI meta-analysis map used as the ground truth summarized 77 neuroimaging studies reporting 773 locations in the brain affected by AD.
Result: The best CNN 5-fold cross validated accuracy reached 87.25% for classifying AD and CN. The best Dice overlap measured for LRP, IG, and GGC, using this model was 0.502 for LRP heatmap, 0.55 for the IG heatmap, and 0.54 for the GGC heatmap. SVM activation patterns achieved a dice of 0.363.
Conclusion: We found that the three heatmap methods capture brain regions that overlap well with the meta-analysis map, and we observed the best overlap for the IG method. All three heatmap methods outperformed linear SVM models suggesting that the deep feature learnt by the most recent deep neural networks can produce more meaningful representations than linear and shallow models.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.089248 | DOI Listing |
Background: Greece has among the largest proportions of elderly worldwide and is among the fastest aging countries in Europe. Consequently, the population suffering from mild cognitive impairment (MCI) or dementia is one of the largest in Europe. This population varies significantly within the different regions in Greece.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Sciences Center at San Antonio, San Antonio, TX, USA.
Background: Deep learning has shown promising results regarding Alzheimer's disease (AD) studies. In the meantime, heatmap methods have emerged as a popular tool to visualize deep learning models, enhancing the transparency and explainability of deep learning. However, when no ground truth is available, the heatmap methods are particularly difficult to trust.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Background: Cardiometabolic disorders are emerging risk factors for Alzheimer's disease (AD) and AD-related dementia (ADRD). There is currently insufficient understanding of how different cardiometabolic profiles and blood biomarkers impact different AD-related brain pathology regionally. This project uses data-driven approaches and explainable artificial intelligence methods to determine the cardiometabolic and fluid contributions toward AD-related pathophysiologic patterns in the brain.
View Article and Find Full Text PDFBackground: Existing therapeutic approaches in Alzheimer's disease (AD) targeting beta-amyloid and tau proteins have shown limited success. Shigellosis, an intestinal infection caused by Shigella, is capable of colonizing the human intestinal epithelium and has been associated with focal adhesions. Rap1 signaling is associated with cancer and cell adhesions.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Pennsylvania, Philadelphia, PA, USA.
Background: Assessment of longitudinal hippocampal atrophy is a well-studied biomarker for Alzheimer's disease (AD). However, most state-of-the-art measurements calculate changes directly from MRI images using image registration/segmentation, which may misreport head motion or MRI artifacts as neurodegeneration. We present a deep learning method Regional Deep Atrophy (RDA) that (1) estimates atrophy sensitive to progression by quantifying time-associated changes in images, especially in preclinical AD stage (as in DeepAtrophy (Dong et al.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!